Learn more

RENOVIS INC

Overview
  • Total Patents
    175
About

RENOVIS INC has a total of 175 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and materials and metallurgy are HERMES SA LAB, ORCHID RES LAB LTD and BUR DANIEL.

Patent filings per year

Chart showing RENOVIS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kincaid John 95
#2 Kelly Michael G 87
#3 Fang Yunfeng 50
#4 Janagani Satyanarayana 49
#5 Wei Zhi-Liang 40
#6 Kaub Carl 39
#7 Wu Guoxian 37
#8 Upasani Ravindra B 37
#9 Duncton Matthew 29
#10 Cao Yeyu 27

Latest patents

Publication Filing date Title
CA2744343A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
CN104058999A Amide Compounds, Compositions And Uses Thereof
WO2009011904A1 Compounds useful as faah modulators and uses thereof
WO2007133637A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2007109154A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109201A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
US2007225324A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109160A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109172A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
CN101443315A Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
CA2641781A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
AP200804620A0 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2007028022A2 Novel compounds as p2x7 modulators and uses thereof
CA2606760A1 Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
US2006217448A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
BRPI0606365A2 compound or a pharmaceutically acceptable salt, solvate or prodrug thereof and stereoisomers and tautomers thereof, pharmaceutical composition, methods for preventing, treating, ameliorating or controlling a disease or condition and for preparing a compound, use of a compound or a salt , solvate or pharmaceutically acceptable composition thereof, method of treating a mammal, and, combination
AP200704119A0 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US2006194801A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
CN101171015A Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same